Pediatric Asthma Controller Trial (PACT)

This study has been completed.

Sponsors and Collaborators:	National Heart, Lung, and Blood Institute (NHLBI) Childhood Asthma Research and Education Network
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00272506

Purpose

To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Condition	Intervention	Phase
Asthma Lung Diseases	Drug: inhaled corticosteroid Drug: long-acting beta2-agonist	Phase III

MedlinePlus related topics: Asthma

Drug Information available for: Corticosteroids Isoetharine Isoetharine hydrochloride Isoetharine mesylate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Crossover Assignment

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	August 2002
Estimated Study Completion Date:	September 2004

Show Detailed Description

Eligibility

Ages Eligible for Study:	up to 18 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00272506

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Childhood Asthma Research and Education Network

Investigators

Investigator:	Vernon Chinchilli	Pennsylvania State University Hershey Medical Center
Investigator:	Robert Lemanske	University of Wisconsin, Madison
Investigator:	Fernando Martinez	University of Arizona
Investigator:	Robert Strunk	Washington University School of Medicine
Investigator:	Stanley Szefler	National Jewish Health
Investigator:	Robert Zeiger	University of California, San Diego

More Information

Study ID Numbers:	351
Study First Received:	January 3, 2006
Last Updated:	July 10, 2006
ClinicalTrials.gov Identifier:	NCT00272506
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases

Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009